EUR 3.77
(-3.58%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 9.72 Million EUR | 1.06% |
2022 | 9.62 Million EUR | 37.27% |
2021 | 7.01 Million EUR | 0.67% |
2020 | 6.96 Million EUR | -12.14% |
2019 | 7.92 Million EUR | -1.33% |
2018 | 8.03 Million EUR | 11.74% |
2017 | 7.18 Million EUR | 0.93% |
2016 | 7.12 Million EUR | 9.32% |
2015 | 6.51 Million EUR | 42.6% |
2014 | 4.56 Million EUR | 122.79% |
2013 | 2.05 Million EUR | 0.19% |
2012 | 2.04 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 8.88 Million EUR | 0.0% |
2024 Q1 | - EUR | -100.0% |
2024 Q3 | - EUR | -100.0% |
2023 Q3 | - EUR | -100.0% |
2023 Q4 | 9.72 Million EUR | 0.0% |
2023 FY | 9.72 Million EUR | 1.06% |
2023 Q1 | - EUR | -100.0% |
2023 Q2 | 9.66 Million EUR | 0.0% |
2022 Q3 | - EUR | -100.0% |
2022 Q2 | 8.91 Million EUR | 0.0% |
2022 Q1 | - EUR | -100.0% |
2022 FY | 9.62 Million EUR | 37.27% |
2022 Q4 | 9.62 Million EUR | 0.0% |
2021 FY | 7.01 Million EUR | 0.67% |
2021 Q2 | 6.94 Million EUR | 0.0% |
2021 Q3 | - EUR | -100.0% |
2021 Q4 | 7.01 Million EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2020 Q2 | 7.73 Million EUR | 0.0% |
2020 Q3 | - EUR | -100.0% |
2020 Q4 | 6.96 Million EUR | 0.0% |
2020 FY | 6.96 Million EUR | -12.14% |
2020 Q1 | - EUR | -100.0% |
2019 Q3 | - EUR | -100.0% |
2019 FY | 7.92 Million EUR | -1.33% |
2019 Q4 | 7.92 Million EUR | 0.0% |
2019 Q2 | 8.41 Million EUR | 0.0% |
2019 Q1 | - EUR | -100.0% |
2018 Q3 | - EUR | -100.0% |
2018 Q4 | 8.03 Million EUR | 0.0% |
2018 FY | 8.03 Million EUR | 11.74% |
2018 Q1 | - EUR | -100.0% |
2018 Q2 | 8.27 Million EUR | 0.0% |
2017 FY | 7.18 Million EUR | 0.93% |
2017 Q1 | - EUR | -100.0% |
2017 Q2 | 6.65 Million EUR | 0.0% |
2017 Q3 | - EUR | -100.0% |
2017 Q4 | 7.18 Million EUR | 0.0% |
2016 FY | 7.12 Million EUR | 9.32% |
2016 Q4 | 7.12 Million EUR | 0.0% |
2016 Q2 | 6.4 Million EUR | 0.0% |
2016 Q1 | - EUR | -100.0% |
2016 Q3 | - EUR | -100.0% |
2015 Q4 | 6.51 Million EUR | 0.0% |
2015 Q1 | - EUR | 0.0% |
2015 FY | 6.51 Million EUR | 42.6% |
2014 FY | 4.56 Million EUR | 122.79% |
2013 FY | 2.05 Million EUR | 0.19% |
2012 FY | 2.04 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BioNTech SE | 357.7 Million EUR | 97.281% |
CureVac N.V. | 24.82 Million EUR | 60.816% |
Biotest Aktiengesellschaft | 419.1 Million EUR | 97.679% |
Biotest Aktiengesellschaft | 419.1 Million EUR | 97.679% |
Formycon AG | 467 Thousand EUR | -1982.655% |
Heidelberg Pharma AG | 10.48 Million EUR | 7.264% |
Medigene AG | 1.00 EUR | -972599900.0% |